Paul Lizzul

Paul Lizzul

Chief Medical OfficeratAnaptysbio· In proxies 2022–2025

Pay in FY2025-48% from the year before · Anaptysbio stock -11.4% the same year

Paul Lizzul was paid $2.4M in FY2025 (Jun), down 48%. Anaptysbio stock fell 11.4% that year.

Pay$100 in the stock at the end of FY21 → $86
Pay is from the Summary Compensation Table of each Anaptysbio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AnaptysbioPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role +204%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?